LEXICON PHARMACEUTICALS, INC. (LXRX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2009: -$89.96M2010: -$95.72M2011: -$114.09M2012: -$108.42M2013: -$102.37M2014: -$100.37M2015: $1.47M2016: -$127.17M2017: -$130.62M2018: -$103.28M2019: $141.44M2020: -$47.80M2021: -$87.09M2022: -$100.76M2023: -$171.75M2024: -$197.12M2025: -$48.91M-$48.91M
2009Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$48.91M+75.2%
2024-$197.12M-14.8%
2023-$171.75M-70.5%
2022-$100.76M-15.7%
2021-$87.09M-82.2%
2020-$47.80M-133.8%
2019$141.44M+237.0%
2018-$103.28M+20.9%
2017-$130.62M-2.7%
2016-$127.17M-8762.9%
2015$1.47M+101.5%
2014-$100.37M+2.0%
2013-$102.37M+5.6%
2012-$108.42M+5.0%
2011-$114.09M-19.2%
2010-$95.72M-6.4%
2009-$89.96M